Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

4.1K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Healing I: Introduction01:11

Healing I: Introduction

14
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
14
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Neutron-to-Hidden-Neutron Oscillations in an Ultracold Neutron Beam.

Physical review letters·2023
Same author

3D multi-cell-type liver organoids: A new model of non-alcoholic fatty liver disease for drug safety assessments.

Toxicology in vitro : an international journal published in association with BIBRA·2023
Same author

[Central toxic keratopathy: A complication of femtoLASIK refractive surgery].

Journal francais d'ophtalmologie·2023
Same author

Publisher's Note: "The very large n2EDM magnetically shielded room with an exceptional performance for fundamental physics measurements" [Rev. Sci. Instrum. 93, 095105 (2022)].

The Review of scientific instruments·2022
Same author

The very large n2EDM magnetically shielded room with an exceptional performance for fundamental physics measurements.

The Review of scientific instruments·2022
Same author

The design of the n2EDM experiment: nEDM Collaboration.

The European physical journal. C, Particles and fields·2021
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

56.5K

[Hepatic fibrogenesis]

O Loréal1, B Clément, Y Deugnier

  • 1Unité de recherches Hépatologiques INSERM U-49, CHRU Pontchaillou, Rennes.

La Revue Du Praticien
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Liver fibrogenesis, driven by hepatic stellate cells and transforming growth factor beta 1, disrupts liver structure and function, leading to cirrhosis. New diagnostic and therapeutic strategies are crucial for managing these chronic liver diseases.

More Related Videos

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

8.6K
3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
06:46

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Published on: February 25, 2022

2.1K

Related Experiment Videos

Last Updated: May 4, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

56.5K
Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
10:42

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration

Published on: May 13, 2016

8.6K
3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
06:46

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Published on: February 25, 2022

2.1K

Area of Science:

  • Hepatology and extracellular matrix biology.
  • Cellular and molecular mechanisms of liver disease.

Context:

  • Chronic liver diseases involve fibrogenesis, an imbalance in extracellular matrix (ECM) synthesis, deposition, and degradation.
  • This imbalance leads to liver fibrosis and cirrhosis, impairing hepatic architecture and function.
  • Hepatic stellate cells are identified as the primary source of ECM components during fibrogenesis.

Purpose:

  • To highlight the central role of transforming growth factor beta 1 (TGF-β1) in liver fibrogenesis.
  • To underscore the need for novel diagnostic and therapeutic approaches targeting liver fibrogenesis.
  • To emphasize the vascular and cellular consequences of fibrogenesis.

Summary:

  • Liver fibrogenesis is a complex process where an imbalance in extracellular matrix dynamics, primarily driven by hepatic stellate cells, leads to liver fibrosis and cirrhosis.
  • Transforming growth factor beta 1 (TGF-β1) is a key mediator in this pathological process.
  • The progression of liver disease necessitates the development of advanced diagnostic tools and targeted therapies.

Impact:

  • Understanding fibrogenesis is critical for developing effective treatments for chronic liver diseases.
  • Targeting hepatic stellate cells and TGF-β1 pathways may offer new therapeutic avenues.
  • Improved diagnostic and therapeutic strategies can mitigate the severe consequences of liver fibrosis and cirrhosis.